iBio (IBIO) Stock Chart & Stock Price History $0.78 +0.01 (+0.73%) As of 03:27 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock iBio Stock Price Performance The iBio (IBIO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 60.70%, with a year-to-date return of -68.08%. In the past month, the stock has increased 6.31%, reflecting recent market activity. As of the latest close, iBio traded at $0.78 with a market cap of $12.82 million and volume of 509,563 shares. Receive IBIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for iBio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.50%1 Month Performance+6.31%3 Month Performance-1.39%Year-To-Date Performance-68.08%1 Year Performance-60.70% IBIO Stock Chart for Friday, August, 22, 2025 IBIO Chart by TradingView iBio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/21/2025$0.76$0.78+2.19%$0.79$0.73509,563 shs$12.82 million08/20/2025$0.73$0.76+3.66%$0.79$0.72731,895 shs$12.55 million08/19/2025$0.74$0.73-1.33%$0.78$0.671.81 million shs$12.11 million08/18/2025$0.74$0.74+0.22%$0.80$0.721.68 million shs$12.27 million08/15/2025$0.68$0.74+9.32%$0.81$0.671.39 million shs$12.24 million08/14/2025$0.73$0.68-7.00%$0.75$0.66961,197 shs$11.20 million08/13/2025$0.57$0.73+27.20%$0.78$0.572.21 million shs$12.04 million08/12/2025$0.59$0.57-2.25%$0.60$0.57226,184 shs$9.47 million08/11/2025$0.59$0.59-1.33%$0.59$0.58197,610 shs$9.69 million08/08/2025$0.59$0.59-0.03%$0.60$0.56445,963 shs$9.82 million Get the Latest News and Ratings for IBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iBio and its competitors with MarketBeat's FREE daily newsletter. 08/07/2025$0.60$0.59-0.10%$0.60$0.58375,130 shs$9.82 million08/06/2025$0.62$0.60-4.48%$0.63$0.59495,571 shs$9.83 million08/05/2025$0.63$0.62-1.64%$0.65$0.62385,314 shs$10.29 million08/04/2025$0.66$0.63-3.90%$0.66$0.63416,433 shs$10.46 million08/01/2025$0.68$0.66-3.09%$0.69$0.65371,327 shs$10.89 million07/31/2025$0.68$0.68-0.29%$0.70$0.67275,737 shs$11.23 million07/30/2025$0.69$0.68-1.15%$0.71$0.67301,043 shs$11.27 million07/29/2025$0.71$0.69-2.83%$0.72$0.67533,283 shs$11.40 million07/28/2025$0.73$0.71-3.15%$0.73$0.70477,173 shs$11.73 million07/25/2025$0.74$0.73-0.88%$0.74$0.73275,117 shs$12.11 million07/24/2025$0.76$0.74-2.77%$0.77$0.74217,915 shs$12.22 million07/23/2025$0.74$0.76+3.41%$0.78$0.74681,643 shs$12.57 million07/22/2025$0.73$0.74+1.22%$0.74$0.72249,499 shs$12.15 million07/21/2025$0.73$0.73-0.59%$0.73$0.72403,691 shs$12.00 million Related Companies IPSC Stock Price Chart STTK Stock Price Chart ALGS Stock Price Chart TPST Stock Price Chart JSPR Stock Price Chart ATHE Stock Price Chart KLRS Stock Price Chart NBRV Stock Price Chart PYRGF Stock Price Chart GRCE Stock Price Chart Receive IBIO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for iBio and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:IBIO) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access